ICON Reports Second Quarter 2012 Revenue up 19% to $277 Million and Non-GAAP EPS of 21c (NASDAQ:ICLR) (ISIN:IE0005711209)
7/24/2012 9:35:04 AM
DUBLIN--(BUSINESS WIRE)--ICON (NASDAQ: ICLR) (ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the second quarter ended June 30, 2012. Net revenue for the quarter was $277 million, an increase of 19% on the prior year. Year to date revenue increased 15% to $529 million from $462 million in 2011.